US at a glance
- Population
- 341.8 million 2025
- Life expectancy at birth
- 78.9 years, 2024
- People aged 65 and over
- 18.4 % of people, 2025
- Health spending per person
- 13,473 US$ per person, 2023
- Doctors
- 3.68 per 1,000 people, 2022
Updated
Reviewed by Chandani Patel
US Neurovascular Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Condition, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$1.15 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.48 Bn | — | — |
| 2025 (base) | $1.57 Bn | +$93.2 Mn | — |
| 2026 (forecast) | $1.67 Bn | +$99.1 Mn | +6.3% |
| 2027 (forecast) | $1.78 Bn | +$105.3 Mn | +13% |
| 2028 (forecast) | $1.89 Bn | +$111.9 Mn | +20.1% |
| 2029 (forecast) | $2.01 Bn | +$119.0 Mn | +27.7% |
| 2030 (forecast) | $2.13 Bn | +$126.5 Mn | +35.7% |
| 2031 (forecast) | $2.27 Bn | +$134.5 Mn | +44.3% |
| 2032 (forecast) | $2.41 Bn | +$142.9 Mn | +53.4% |
| 2033 (forecast) | $2.56 Bn | +$151.9 Mn | +63% |
| 2034 (forecast) | $2.73 Bn | +$161.5 Mn | +73.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.57 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $2.73 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 6.3% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, condition and end user (see all) |
| Key players | Stryker, Medtronic, Penumbra, Johnson & Johnson, MicroVention (Terumo) (see all) |
| Regulator in the US | FDASource: US Food and Drug Administration. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Neurovascular devices treat stroke and brain aneurysms through catheters, using clot-removal devices, coils, stents and flow diverters.
Key segments of the neurovascular Devices market include product (Stent Retrievers, Aspiration Catheters and Embolic Coils) and condition (Ischemic Stroke, Brain Aneurysm and AV Malformations).
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the neurovascular Devices market.
Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the neurovascular Devices market strong room to grow.
Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the neurovascular Devices market.
The neurovascular Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA).[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).[2]
[1] US Food and Drug Administration. Checked 14 Nov 2026.
[2] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how neurovascular Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.
What doctors and scientists are doing in Neurovascular Devices right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
Digital Health · US
Pharmaceuticals · US
Pharmaceuticals · US
Healthcare Services · US
Pharmaceuticals · US
Pharmaceuticals · US